These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 30025477)
1. Compound Heterozygosity for Hb Adana (HBA2: c.179G>A) and the -α Theodoridou S; Teli A; Yfanti E; Vyzantiadis TA; Theodoridis T; Economou M Hemoglobin; 2018 Mar; 42(2):129-131. PubMed ID: 30025477 [TBL] [Abstract][Full Text] [Related]
2. A Unique Interaction of IVS-I-1 (G>A) (HBA2: c.95+1G>A) with Hb Adana (HBA2: c.179G>A) Presenting as Transfusion-Dependent α-Thalassemia. Alauddin H; Kamarudin K; Loong TY; Azma RZ; Ithnin A; Jalil N; Razak NF; Koh-Xuan-Rong D; Ismail E; C-Khai L; Abdul Latiff Z; Alias H; Othman A Hemoglobin; 2018 Jul; 42(4):247-251. PubMed ID: 30623696 [TBL] [Abstract][Full Text] [Related]
3. Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype-phenotype correlation. Singh SA; Sarangi S; Appiah-Kubi A; Hsu P; Smith WB; Gallagher PG; Glader B; Chui DHK Pediatr Blood Cancer; 2018 Sep; 65(9):e27220. PubMed ID: 29749692 [TBL] [Abstract][Full Text] [Related]
4. DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia. Tan JAMA; Kho SL; Ngim CF; Chua KH; Goh AS; Yeoh SL; George E Sci Rep; 2016 Jun; 6():26994. PubMed ID: 27271331 [TBL] [Abstract][Full Text] [Related]
5. Severe α-Thalassemia Due to Compound Heterozygosity for Hb Adana (α59 Gly>Asp) ( Azimi A; Tahmasebi S; Moradi K; Nejati P; Alibakhshi R Hemoglobin; 2020 Mar; 44(2):139-142. PubMed ID: 32498570 [TBL] [Abstract][Full Text] [Related]
6. A case series of α-thalassemia intermedia due to compound heterozygosity for Hb Adana [HBA2: c179G>A (or HBA1); p.Gly60Asp] with other α-thalassemias in Malay families. Alauddin H; Jaapar NA; Azma RZ; Ithnin A; Razak NF; Loh CK; Alias H; Abdul-Latiff Z; Othman A Hemoglobin; 2014; 38(4):277-81. PubMed ID: 24829075 [TBL] [Abstract][Full Text] [Related]
7. Interaction of Hb adana (HBA2: c.179G>A) with deletional and nondeletional α(+)-thalassemia mutations: diverse hematological and clinical features. Nainggolan IM; Harahap A; Ambarwati DD; Liliani RV; Megawati D; Swastika M; Setianingsih I Hemoglobin; 2013; 37(3):297-305. PubMed ID: 23614625 [TBL] [Abstract][Full Text] [Related]
8. Severe α-thalassemia intermedia due to a compound heterozygosity for the highly unstable Hb Adana (HBA2: c.179G>A) and a novel codon 24 (HBA2: c.75T>A) mutation. Megawati D; Nainggolan IM; Swastika M; Susanah S; Mose JC; Harahap AR; Setianingsih I Hemoglobin; 2014; 38(2):149-51. PubMed ID: 24351118 [TBL] [Abstract][Full Text] [Related]
10. A Novel Mutation of the α2-Globin Gene Causing α Chen B; Lin L; Yi S; Chen Q; Wei H; Li G; Zheng C; He S; Qiu X Hemoglobin; 2017 Jan; 41(1):56-58. PubMed ID: 28395547 [TBL] [Abstract][Full Text] [Related]
11. [Prenatal diagnosis of Thailand deletion of α-thalassemia 1 families]. Lin N; Lin Y; Huang HL; Lin XL; He DQ; He SQ; Guo DH; Li Y; Xu LP Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(24):1919-22. PubMed ID: 27373361 [TBL] [Abstract][Full Text] [Related]
12. A clinical update of compound heterozygosity for hemoglobin Hekinan II [a27(B8)Glu-Asp; HBA1: c.84G>T] variant in China. Pan L; Qiu Y; Ye L; Li L; Huang Y; Mo W; Lin F Lab Med; 2024 Sep; 55(5):615-619. PubMed ID: 38581097 [TBL] [Abstract][Full Text] [Related]
13. Prevention of Hb Bart's (γ4) Disease Associated with the - -(THAI) α(0)-Thalassemia Deletion in Mainland China. Li DZ; Li Y; Li J; Li SC; Li R Hemoglobin; 2015; 39(6):412-4. PubMed ID: 26212676 [TBL] [Abstract][Full Text] [Related]
14. Hb H Hydrops Fetalis Syndrome Caused by Association of the - -(SEA) Deletion and Hb Constant Spring (HBA2: c.427T > C) Mutation in a Chinese Family. He S; Zheng C; Meng D; Chen R; Zhang Q; Tian X; Chen S Hemoglobin; 2015; 39(3):216-9. PubMed ID: 25897478 [TBL] [Abstract][Full Text] [Related]
15. Hydrops Fetalis Associated with Compound Heterozygosity for Hb Zurich-Albisrieden (HBA2: C.178G > C) and the Southeast Asian (- - Yang X; Yan JM; Li J; Xie XM; Zhou JY; Li Y; Li DZ Hemoglobin; 2016 Sep; 40(5):353-355. PubMed ID: 27686733 [TBL] [Abstract][Full Text] [Related]
16. Hematological Characteristics of Hb Constant Spring ( Jiang F; Xu LL; Chen GL; Zhou JY; Li J; Tang XW; Zuo LD; Li DZ Hemoglobin; 2020 Mar; 44(2):86-88. PubMed ID: 32338097 [TBL] [Abstract][Full Text] [Related]
17. First Report of a Coincidental Discovery of Hb Shimonoseki [α54(E3)Gln→Arg, HBA2: c.164A > G (or HBA1)] in a Greek Family. Theodoridou S; Delaki E; Skatharoudi E; Karakasidou O; Vyzantiadis TA; Theodoridis T; Chalkia P Hemoglobin; 2018 Jul; 42(4):281-282. PubMed ID: 30821196 [TBL] [Abstract][Full Text] [Related]
18. Hematological characterization of compound heterozygous hemoglobin Hope/E patients with and without alpha-thalassemia-1 SEA type deletion. Pornprasert S Clin Lab; 2013; 59(9-10):1183-5. PubMed ID: 24273946 [TBL] [Abstract][Full Text] [Related]
19. First Case of a Compound Heterozygosity for Two Nondeletional α-Thalassemia mutations, Hb Constant Spring and Hb Quong Sze. Zhou JY; Yan JM; Li J; Li DZ Hemoglobin; 2016 Jun; 40(3):210-2. PubMed ID: 26956449 [TBL] [Abstract][Full Text] [Related]
20. A rare thalassemic syndrome caused by interaction of Hb Adana [alpha59(E8)Gly-->Asp] with an alpha+-thalassemia deletion: clinical aspects in two cases. Douna V; Papassotiriou I; Garoufi A; Georgouli E; Ladis V; Stamoulakatou A; Metaxotou-Mavrommati A; Kanavakis E; Traeger-Synodinos J Hemoglobin; 2008; 32(4):361-9. PubMed ID: 18654886 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]